alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 99.2





PERICOM SEMICONDUCTOR
CORPORATION



CERTIFICATION OF CHIEF FINANCIAL
OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with this quarterly report of Pericom Semiconductor Corporation (the Company) on Form 10-Q for the period ended December 31,
2002 (the Report), I, Michael D. Craighead, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my
knowledge:



(1) the Report fully complies with
the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and



(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company at the dates and for the periods indicated.



|                       
|-----------------------
|Date: February 11, 2003
|
# C_2021351EN.01001801.xml

| 1.9.2021 | EN | Official Journal of the European Union | C 351/18 |
| --- | --- | --- | --- |

1.9.2021

EN

Official Journal of the European Union

C 351/18

---

Non-opposition to a notified concentration

(Case M.10291 — Arçelik/Whirlpool Beyaz)

(Text with EEA relevance)

(2021/C 351/05)

On 18 June 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10291. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10291. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<CIK> 0001018744
<NAME> OVLC FINANCIAL CORP.
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1997
<PERIOD-START>                             OCT-01-1996
<PERIOD-END>                               SEP-30-1997
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   1,000
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                     1,000
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
Court of Appeals

Sixth Appellate District of Texas

J U D G M E N T

David Nickolas Armstrong, Appellant

No. 06-18-00148-CR v.

The State of Texas, Appellee

Appeal from the 271st District Court of Wise 

County, Texas (Tr. Ct. No. CR19652). 

Opinion delivered by Chief Justice Morriss, 

Justice Burgess and Justice Stevens 

participating.

As stated in the Court’s opinion of this date, we find there was partial error in the judgment 

of the court below. Therefore, we modify the trial court’s judgment to reflect the proper degree of 

offense as a third-degree felony. As modified, the judgment of the trial court is affirmed.

We note that the appellant, David Nickolas Armstrong, has adequately indicated his 

inability to pay costs of appeal. Therefore, we waive payment of costs.

RENDERED MARCH 13, 2019

BY ORDER OF THE COURT

JOSH R. MORRISS, III

CHIEF JUSTICE

ATTEST:

Debra K. Autrey, Clerk
Exhibit 31.2
 CERTIFICATION PURSUANT TO RULE 15D-14 OF THE SECURITIES EXCHANGE
ACT OF 1934, AS AMENDED AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
  1.
    
    I have reviewed this annual report on Form 10-K/A of ACE*COMM Corporation;2.
    
    Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered
by this report.
  /s/ Steven R. DelmarSteven R. DelmarPrincipal Financial Officer
#### All data considered provisional and subject to revision.

      Pool Elevation                    
csv

      Storage                    
csv

      Total Release                    
csv

#### All data considered provisional and subject to revision.

      Pool Elevation                    
json

      Storage                    
json

      Total Release                    
json
<PAGE>

Exhibit 99

Letter of Arthur Andersen LLP Representation

To the Securities and Exchange Commission:

The Company has received a letter from Arthur Andersen LLP, dated March 29,
2002, representing that the audit was subject to their quality control system
for the U.S. accounting and auditing practice to provide reasonable assurance
that the engagement was conducted in compliance with professional standards,
that there was appropriate continuity of Arthur Andersen LLP personnel working
on the audit and availability of national office consultation. The letter also
noted that availability of personnel at foreign affiliates of Arthur Andersen
LLP was not relevant to the Company's audit.


BY: /S/ EDWIN THARP

Edwin Tharp
CFO and COO
EXHIBIT 32.1
 
 CERTIFICATION
 OF
 CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
 
 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Manhattan Pharmaceuticals, Inc. do hereby certify that:
 
 (a)  the Quarterly Report on Form 10-QSB of Manhattan Pharmaceuticals, Inc. for the quarter ended September 30, 2003 (the Report:) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (b)  information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Manhattan Pharmaceuticals, Inc.
 
 Date: August 16, 2004
By:
/s/ Leonard FirestoneLeonard FirestonePresident and Chief Executive Officer




|                      |                                                                          |                          
|--------------------- | ------------------------------------------------------------------------ | -------------------------
|                      |                                                                         
|                      |                                                                          |                          
|Date: August 16, 2004 | By:                                                                      | /s/ Nicholas J. Rossettos
|                      |                                                                         
|                      | Nicholas J. RossettosChief Financial Officer and Chief Operating Officer
# C_2021472EN.01000201.xml

| 23.11.2021 | EN | Official Journal of the European Union | C 472/2 |
| --- | --- | --- | --- |

23.11.2021

EN

Official Journal of the European Union

C 472/2

---

Non-opposition to a notified concentration

(Case M.10501 – BOUYGUES / DESTIA)

(Text with EEA relevance)

(2021/C 472/02)

On 16 November 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10501. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10501. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
1 The HONORABLE RICHARD G. KOPF, Chief Judge, United States District Court for the District of Nebraska. 

## United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 01-2998

___________ United States of America, * * Appellee, * Appeal from the United States * District Court for the v. * District of Nebraska. * Juan Jose Padilla, * [UNPUBLISHED] * Appellant. *

___________ Submitted: February 5, 2002 Filed: February 6, 2002

___________ Before LOKEN, BEAM, and RILEY, Circuit Judges.

___________ PER CURIAM. A jury found Juan Jose Padilla guilty of conspiring to distribute at least 50 but less than 500 grams of methamphetamine. The district court 1 sentenced him to 78 months in prison and five years supervised release. Padilla appeals, challenging the sufficiency of the evidence and the denial of his request for a downward departure. We affirm.-2- At trial, two witnesses testified that Padilla sold them resale quantities of methamphetamine, and introduced one of them to other methamphetamine sources. Another witness testified that Padilla and an alleged conspirator provided a reseller with methamphetamine which was stored for later distribution. The jurors were free to accept or reject any witness’s testimony in whole or in part. See United States v. One Star , 979 F.2d 1319, 1321(8th Cir. 1992). Examining the evidence in the light most favorable to the jury verdict and giving the verdict the benefit of all reasonable inferences, see United States v. Robinson , 217 F.3d 560, 564 (8th Cir.), cert. denied , 531 U.S. 999 (2000), we conclude the evidence supports Padilla’s conspiracy conviction. See United States v. Miller , 91 F.3d 1160, 1162 (8th Cir. 1996) (evidence of multiple sales of resale quantities of drugs is sufficient to make submissible case of conspiracy to distribute); United States v. Dugan , 238 F.3d 1041, 1044-45 (8th Cir. 2001) (appellate court does not reweigh evidence or judge credibility of witnesses). The district court’s discretionary decision to deny Padilla’s request to depart downward is unreviewable. SeeUnited States v. Saelee , 123 F.3d 1024, 1025 (8th Cir. 1997). Accordingly, we affirm and deny Padilla’s pending motion for new counsel. A true copy.
Attest: CLERK, U. S. COURT OF APPEALS, EIGHTH CIRCUIT.
# C_2021309EN.01000501.xml

| 2.8.2021 | EN | Official Journal of the European Union | C 309/5 |
| --- | --- | --- | --- |

2.8.2021

EN

Official Journal of the European Union

C 309/5

---

Non-opposition to a notified concentration

(Case M.10317 — Macquarie/Warburg Pincus/PTSG)

(Text with EEA relevance)

(2021/C 309/05)

On 8 July 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10317. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10317. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
# C_2021393EN.01000301.xml

| 29.9.2021 | EN | Official Journal of the European Union | C 393/3 |
| --- | --- | --- | --- |

29.9.2021

EN

Official Journal of the European Union

C 393/3

---

Non-opposition to a notified concentration

(Case M.10368 – Advent/Eurazeo/Hoist)

(Text with EEA relevance)

(2021/C 393/03)

On 16 September 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10368. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10368. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Listen

# Advisory Committees Reports

The findings and recommendations contained in these reports are the views of a majority of the members of the advisory committees that produced them and do not necessarily represent the views of the Commission, its individual members, nor the policies of the United States government.

Statement of the Maryland Advisory Committee on Anti-Asian Hate Crimes and Violence
April 12, 2021

Disparate and Punitive Impact of Exclusionary Practices on Students of Color, Students with Disabilities and LGBTQ Students in Pennsylvania Public Schools
April 9, 2021

Civil Rights and the Impact of Native American Names, Symbols, and Imagery in School Mascots in Nebraska
March 15, 2021

Civil Rights and Equity in the Delivery of Medical and Public Services During the COVID-19 Pandemic in Ohio
February 8, 2021

Turning Off the Tap: Massachusetts' Looming Water Affordability Crisis
January 27, 2021

Understanding the Impact of Immigration Enforcement on California Children in K-12 Schools
January 25, 2021

Hate Crime Statistics and Incidence in Virginia
November 23, 2020

-    First  
-    Previous  
-   ...  
-  3 
-  4 
-  5 
-  6 
-  7 

-  All Reports 
-  Annual Statutory Enforcement 
-  Briefing Reports 
-  Advisory Committees Reports 
-  Budget and Performance 
-  FOIA Reports 
-  Data Inventory Program 
-  Civil Rights Complaints 
-  Historical Publications 
-  Archives
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

MARIE JEANLIUS, )

)

Appellant, )

)

v. ) Case No. 2D17-2123

)

NAPLES GRANDE BEACH )

RESORT, )

)

Appellee. )

)

Opinion filed April 24, 2019.

Appeal from the Commission on 

Human Relations; Lee County.

Marie Jeanlius, pro se.

Laura E. Prather and Nicole

Santamaria of Jackson Lewis, P.C., 

Tampa, for Appellee.

PER CURIAM.

Affirmed. 

CASANUEVA, MORRIS, and SMITH, JJ., Concur.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF BLOUNT INTERNATIONAL, INC. FOR THE PERIOD ENDED
MARCH 31, 1998, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                         DEC-31-1998
<PERIOD-END>                              MAR-31-1998
<CASH>                                           4,314
<SECURITIES>                                         0
<RECEIVABLES>                                  161,414
<ALLOWANCES>                                     4,136
<INVENTORY>                                    140,556
<CURRENT-ASSETS>                               329,837
<PP&E>                                         382,362
<DEPRECIATION>                                 194,223
<TOTAL-ASSETS>                                 664,899
<CURRENT-LIABILITIES>                          144,098
<BONDS>                                        140,426
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           389
<OTHER-SE>                                     328,144
<TOTAL-LIABILITY-AND-EQUITY>                   664,899
<SALES>                                        199,734
<TOTAL-REVENUES>                               199,734
<CGS>                                          139,229
<TOTAL-COSTS>                                  139,229
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,031
<INCOME-PRETAX>                                 22,287
<INCOME-TAX>                                     8,580
<INCOME-CONTINUING>                             13,707
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    13,707
<EPS-PRIMARY>                                     0.37
<EPS-DILUTED>                                     0.36
        


</TABLE>
#### All data considered provisional and subject to revision.

      Storage                    
csv

      Inflow                    
csv

      Total Release                    
csv

      Pool Elevation                    
csv

      Delta Storage                    
csv

      Area                    
csv

      Evaporation                    
csv

      Release Volume                    
csv

      Inflow Volume                    
csv

#### All data considered provisional and subject to revision.

      Storage                    
json

      Inflow                    
json

      Total Release                    
json

      Pool Elevation                    
json

      Delta Storage                    
json

      Area                    
json

      Evaporation                    
json

      Release Volume                    
json

      Inflow Volume                    
json
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF INTERNET AMERICA, INC. FOR THE THREE MONTHS ENDED
SEPTEMBER 30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           1,280
<SECURITIES>                                         0
<RECEIVABLES>                                    3,130
<ALLOWANCES>                                       541
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 4,315
<PP&E>                                           6,091
<DEPRECIATION>                                   3,556
<TOTAL-ASSETS>                                  36,147
<CURRENT-LIABILITIES>                           11,302
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            99
<OTHER-SE>                                      24,523
<TOTAL-LIABILITY-AND-EQUITY>                    36,147
<SALES>                                              0
<TOTAL-REVENUES>                                 8,967
<CGS>                                            5,786
<TOTAL-COSTS>                                   14,001
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   4
<INCOME-PRETAX>                                (5,038)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (5,038)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,038)
<EPS-BASIC>                                     (0.52)
<EPS-DILUTED>                                   (0.52)


</TABLE>